证券代码：688016 证券简称：心脉医疗 公告编号：2026-002

Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management, focusing on high-security and liquid investment products to enhance fund efficiency and maximize shareholder returns [2][3][19]. Investment Overview - Investment Purpose: The company aims to maximize shareholder interests by efficiently using temporarily idle raised funds for cash management without affecting the normal investment plans [3]. - Investment Amount: The company plans to use no more than RMB 100,000 million (including principal) for cash management [4][13]. - Funding Source: As of June 30, 2025, the company has detailed the status of funds raised from its initial public offering in 2019 and subsequent fundraising activities [5][6]. Investment Method - Investment Products: The company intends to invest in high-security and liquid products, including but not limited to structured deposits, notice deposits, time deposits, large-denomination certificates of deposit, and income certificates [7][11]. - Investment Duration: The investment period is set for 12 months from the date of approval by the board of directors [8][13]. - Implementation Method: The board authorizes the management team to handle the purchase of investment products, with the finance department responsible for organizing the implementation [9][13]. Cash Management Returns - Return Allocation: The returns from cash management will be prioritized for supplementing any shortfall in investment amounts for projects and for the company's daily operational liquidity, adhering to regulatory requirements [10][19]. Recent Cash Management Situation - The company previously approved the use of up to RMB 130,000 million for cash management, maintaining the same focus on high-security and liquid products [11][12]. Review Procedures - The board of directors approved the cash management proposal on January 19, 2026, ensuring it does not impact the normal operation of investment plans [13][19]. Impact on the Company - The planned use of idle raised funds for cash management will not affect the normal turnover of funds or the operation of investment projects, and it aims to improve fund efficiency and provide better returns for shareholders [17][19].